Hillsdale Investment Management Inc. Purchases 6,400 Shares of Dolby Laboratories $DLB

Hillsdale Investment Management Inc. increased its position in Dolby Laboratories (NYSE:DLB) by 39.0% during the second quarter, HoldingsChannel reports. The institutional investor owned 22,800 shares of the electronics maker’s stock after acquiring an additional 6,400 shares during the period. Hillsdale Investment Management Inc.’s holdings in Dolby Laboratories were worth $1,693,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Dolby Laboratories by 7.1% during the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after purchasing an additional 502,110 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Dolby Laboratories by 7.8% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 15,777 shares of the electronics maker’s stock worth $1,172,000 after purchasing an additional 1,146 shares in the last quarter. Fiera Capital Corp increased its position in Dolby Laboratories by 19.0% during the first quarter. Fiera Capital Corp now owns 639,404 shares of the electronics maker’s stock worth $51,351,000 after buying an additional 102,028 shares during the last quarter. Comerica Bank increased its position in Dolby Laboratories by 83.2% during the first quarter. Comerica Bank now owns 105,570 shares of the electronics maker’s stock worth $8,478,000 after buying an additional 47,936 shares during the last quarter. Finally, Ethic Inc. bought a new position in Dolby Laboratories during the first quarter valued at about $536,000. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 38.39% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DLB. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Tigress Financial increased their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a report on Friday, August 15th. Barrington Research dropped their price target on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Rosenblatt Securities reduced their price objective on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

Dolby Laboratories Trading Up 3.1%

Shares of NYSE:DLB opened at $67.52 on Friday. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The firm has a market capitalization of $6.47 billion, a PE ratio of 24.73 and a beta of 0.97. The business’s 50 day moving average is $68.59 and its 200-day moving average is $72.35.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.Dolby Laboratories’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the company posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be given a dividend of $0.36 per share. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date is Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 54.75%.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.